Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginally
- 1 October 1984
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 30 (4) , 381-389
- https://doi.org/10.1016/s0010-7824(84)80030-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Pharmacokinetics and metabolism of moxestrol in humansThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435Contraception, 1982
- Long-term Contraception with a single implant of the progestin ST-1435Fertility and Sterility, 1981
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435Contraception, 1981
- PLASMA LEVELS OF NORETHINDRONE AFTER SINGLE ORAL DOSE ADMINISTRATION OF NORETHINDRONE AND LYNESTRENOLClinical Endocrinology, 1979
- Individual Differences in the Disposition of Drugs Metabolised in the BodyClinical Pharmacokinetics, 1978
- RELATION BETWEEN SEX HORMONE BINDING GLOBULIN AND D-NORGESTREL LEVELS IN PLASMAActa Endocrinologica, 1977
- Intravaginal contraception with the synthetic progestin, R2323Contraception, 1976
- Contraception with d-norgestrei silastic rods. Plasma levels of d-norgestrel and influence on the ovarian functionContraception, 1976
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976